Skip to Content

A knowledge base
for the global
CDG community

CDG Hub is a knowledge base that is designed to educate researchers, clinicians, patients and families on congenital disorders of glycosylation.

CDG Hub is a nexus for curated information on more than 170+ CDG types, clinical trials, research models and resources, including a database of CDG medical experts and researchers worldwide. CDG Hub aims to unite the global CDG community, increase public awareness, and inspire collaborative research to advance scientific discoveries.

Congenital Disorders of Glycosylation

Congenital Disorders of Glycosylation (CDG) are a large group of rare, inherited disorders that are caused by defects in glycosylation.

Glycosylation is the process of assembling and adding sugar chains, called glycans, to proteins and lipids. When someone has CDG, their body cannot properly create or add glycans to proteins and lipids.

As every part of the body needs glycosylation to work properly, people with CDG have many health problems which often affect multiple body systems. There is no cure for CDG, but treatments are available to manage symptoms and many therapies are currently in development.


There are 170+ different types of CDG and new types are discovered each year.


Over 400 genes in the human genome are involved in glycosylation and mutations in more than 170 of them are known to cause CDG.


Learn everything you need to know about CDG. Discover educational resources developed specifically for families, important medical terms to know, FAQs, and connect with other CDG families near you!


Are you a healthcare professional interested in learning about CDG? Discover educational resources for clinicians and patients, CDG medical experts and centres around the world and upcoming clinical trials.


Our understanding of CDG continues to evolve as researchers around the world study what causes the disease and how it affects the body. Discover researchers who are working to better understand CDG, improve diagnosis and develop new treatments or cures. Be inspired to launch collaborative research projects to accelerate scientific discoveries on CDG!

Join CDG Connect PIN: a worldwide CDG patient registry

Help advance progress towards improved diagnosis, treatments and cures for CDG by joining a global patient registry.


September 3, 2024

SSIEM Annual Symposium 2024

September 3, 2024 / Porto, Portugal


November 10, 2024

Society for Glycobiology Annual Meeting 2024

November 10, 2024 / Amelia Island, FL, United States



June 1, 2024

NANS-CDG: Expanding clinical insights with a novel patient with novel variants

Yoo S, Cheon CK. Am J Med Genet A., June 1, 2024


June 1, 2024

Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center

Yüksel MF, Doğulu N, Yıldırım M, Köse E, Bektaş Ö, Eminoğlu FT, Teber S. Brain Dev. , June 1, 2024


May 17, 2024

Droplet Microfluidics with Capillary Electrophoresis for Glycan Biomarker Analysis

Liénard-Mayor T, Bricteux C, Tran NT, Bruneel A, Taverna M, Mai TD. Methods Mol Biol., May 17, 2024


May 14, 2024

Destabilization and Degradation of a Disease-Linked PGM1 Protein Variant

Gouliaev F, Jonsson N, Gersing S, Lisby M, Lindorff-Larsen K, Hartmann-Petersen R. Biochemistry., May 14, 2024


May 10, 2024

Normal transferrin glycosylation does not rule out severe ALG1 deficiency

Bosnyak I, Sadek M, Ranatunga W, Kozicz T, Morava E. JIMD, May 10, 2024